| Expression pattern: |
UP |
| Associated gene: |
TGFB2, AGO2 |
| Associated microRNA: |
hsa-miRNA-599, miRNA-599 |
| Biological function: |
promotes osteosarcoma cell proliferation, migration, tumor growth, and metastasis |
| Molecular mechanism: |
circ-0000285 functions as a ceRNA by sponging miRNA-599 and positively regulating TGFB2 expression |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); metastasis (promotes); ceRNA regulation (promotes); other pathway/process (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Sanger Sequencing; RNase R Treatment; RT-qPCR; Microarray; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; Colony Formation Assay; EdU Staining; Transwell Assay; Wound Healing Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; H&E Staining; Bioinformatics Analysis |
| Clinical significance: |
providing a novel direction for clinical diagnosis and treatment of osteosarcoma |
| Description: |
Hsa_circ_0000285/circ-0000285 is up-regulated in osteosarcoma cell lines and promotes osteosarcoma proliferation, migration, tumor growth, and metastatic nodule formation. Mechanistically, it is mainly cytoplasmic and functions as a ceRNA that sponges miRNA-599, thereby positively regulating TGFB2 expression through the circ-0000285/miRNA-599/TGFB2 axis. |
| Confidence score: |
0.8207 |